Asked by: Caroline Voaden (Liberal Democrat - South Devon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support biomedical research into (a) long covid and (b) myalgic encephalomyelitis.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department funds research on health and social care through the National Institute for Health and Care Research (NIHR). The NIHR welcomes funding applications for research into any aspect of human health, including long COVID and myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS). The NIHR and the Medical Research Council (MRC) are committed to funding high-quality research to understand the causes, consequences, and treatment of long COVID and ME/CFS, and are actively exploring next steps for research in these areas.
Over the last five years, the Government, through the NIHR and the MRC, has invested over £50 million into long COVID research through two specific research calls. The projects funded aim to improve our understanding of the diagnosis and underlying mechanisms of the disease, and the effectiveness of both pharmacological and non-pharmacological therapies and interventions, as well as to evaluate clinical care.
The MRC has provided £4.15 million of ME/CFS research funding since 2013, including £3.19 million jointly awarded with the NIHR for the DecodeME project, which aims to find genetic risk factors of ME/CFS to better understand the disease and ultimately to find treatments. The NIHR has committed approximately £3.9 million of programme funding over the same period.
As findings emerge from current research, we encourage researchers to apply for funding to build on and develop the newly established infrastructure, partnerships, and research capabilities. Government research funders remain available to support long COVID and ME/CFS researchers in their applications for funding.